New Delhi: Fortis Memorial Research Institute, Gurugram on Sunday started the trial run of Sputnik V vaccine for the general public, news agency ANI reported. Earlier this month, the Drug Controller General of India (DCGI), Dr VG Somani granted the Serum Institute of India (SII) to manufacture the Russian-made Sputnik V vaccine against the coronavirus disease (Covid-19).Also Read - Delhi Govt Converts 4 Private Hospitals Into Dedicated Omicron Centres. Details Here

“The DCGI has granted permission to the Serum Institute to manufacture the Sputnik Covid-19 vaccine in India for examination, test, and analysis at its licensed Hadapsar facility with certain conditions,” news agency PTI reported, citing official sources. Also Read - Malvinder files complaint against Shivinder, spiritual leader; alleges cheating, siphoning of funds

Earlier today, the roll-out of the Russian COVID-19 vaccine ‘Sputnik V’ at various private hospitals in the Delhi-NCR region was delayed again. “We do not have a clarity on the dates of the vaccine roll-out,” a spokesman of Apollo Hospitals said. Also Read - Celebratory firing: Family of deceased woman donates her kidneys

Indraprastha Apollo here had earlier said that it would tentatively start administering the two-dose vaccine by June 25.

An official of Madhukar Rainbow Children’s Hospital said the facility has also not received Sputnik V doses so far from Hyderabad-based Dr Reddy’s Laboratories, the marketing partner for the vaccine in the country.

“There is a delay on the part of the suppliers. They have not shared any specific reason for it. I think it could be related to the supply of both the doses together,” he said. Sputnik V uses two different viruses that cause the common cold (adenovirus) in humans. The two doses, given 21 days apart, are different and not interchangeable.

Fortis Healthcare, which had said that it would make Sputnik V available at its Gurgaon and Mohali hospitals, has also not started administering the Russian vaccine to people so far. The Centre has fixed the price of the vaccine at Rs 1,145 per dose. The maximum price of Covishield for private COVID-19 Vaccination Centres (CVCs) has been fixed at RS 780 per dose, while that of Covaxin at Rs 1,410 per dose.

(With agency inputs)